January 21, Pre-market – $Johnson & Johnson (JNJ.US)$ released its fourth-quarter 2025 earnings report. The company once again beat top-line expectations, with the Innovative Medicine business recording double-digit growth, accompanied by clear guidance indicating a solid execution path forward.
Key Q4 & Full-Year Highlights
– Q4 Revenue: Sales rose 9.1% to $24.56 billion, beating analyst estimates of $24.16 billion. Operational growth was 7.1% ...

$Milestone Pharmaceuticals (MIST.US)$ $8 dollar Profit Target set by so many analysts. bullish! 🔥

$Cypherpunk Technologies (CYPH.US)$
$Vor Biopharma (VOR.US)$
$SMX (Security Matters) (SMX.US)$
chasing after these will turn you into a bag holder until the end of time
low float pump and dumps happen because of squeezes - and they don't usually happen twice. once dilution and volume sets in they are done forever - just look at where AMC and GME are. Did they moon? No.

$Aimei Health Technology (AFJK.US)$ end of year junk stocks flying all over trying to give investors a eoy return on the chart. This cycle is far more dangerous as green as it may look, don't get caught up in market euphoria and lose sight of your principles. could cost you.

$Cemtrex (CETX.US)$ absolutely disgusting

$Cemtrex (CETX.US)$ have a stop loss people

$Cemtrex (CETX.US)$ IM SO FUCKING MAD OMG

$Cemtrex (CETX.US)$ i just lost all the money i made today

$Cemtrex (CETX.US)$ will you go to 20